Methylphenidate (MP) is primarily prescribed for attention-deficit/hyperactivity disorder, but it is also misused as a cognitive
enhancer by individuals seeking to improve cognitive performance. Using advanced brain imaging and behavioral tasks, this
study investigates how MP affects dopamine signaling, brain activity, and cognitive performance. Our results demonstrate
that MP promoted a frontoparietal-dominant brain state which linked to improved task performance and D1 receptor
availability. This research also introduces a multilevel neuroimaging approach to studying drug effects, offering a foundation
for tailoring interventions by predicting individual variations in responses to medicine.
Yan W, Demiral ŞB, Tomasi D, Zhang R, Manza P, Wang GJ, Volkow ND. Methylphenidate promotes a frontoparietal-dominant brain state improving cognitive performance: a randomized trial. J Neurosci. 2025 Mar 18